Literature DB >> 22968740

Clinical, immunological and molecular characterization of DOCK8 and DOCK8-like deficient patients: single center experience of twenty-five patients.

Zobaida Alsum1, Abbas Hawwari, Osama Alsmadi, Safa Al-Hissi, Esteban Borrero, Asma' Abu-Staiteh, Hanif G Khalak, Salma Wakil, Abdelmoneim M Eldali, Rand Arnaout, Abdulaziz Al-Ghonaium, Saleh Al-Muhsen, Hasan Al-Dhekri, Bandar Al-Saud, Hamoud Al-Mousa.   

Abstract

PURPOSE: Autosomal recessive hyper-IgE syndrome is a rare combined immunodeficiency characterized by susceptibility to viral infections, atopic eczema, high serum IgE and defective T cell activation. The genetic etiologies are diverse. Null mutations in DOCK8 and TYK2 are responsible for many cases. This study aims to provide a detailed clinical and immunological characterization of the disease and explore the underlying genetic defects among a large series of patients followed by a single center. The available data might improve our understanding of the disease pathogenesis and prognosis.
METHODS: Clinical data of twenty-five patients diagnosed with AR-HIES were collected. Seventeen patients screened for STAT3, TYK2 and DOCK8 mutations.
RESULTS: Sinopulmonary infections, dermatitis, hepatic disorders, cutaneous and systemic bacterial, fungal and viral infections were the most common clinical features. The rate of hepatic disorders and systemic infections were high. Twelve patients died with a median age of 10 years. CMV infection was the only statistically significant predicting factor for poor prognosis (early death). Three novel DOCK8 mutations and two large deletions were found in thirteen patients. No mutations found in STAT3 or TYK2 genes.
CONCLUSION: Autosomal recessive hyper-IgE syndrome is a combined immunodeficiency disease characterized by high morbidity and mortality rate. The different genetic background and environmental factors may explain the more severe phenotypes seen in our series. DOCK8 defect is the most common identified genetic cause. Patients with no identified genetic etiology are likely to carry mutations in the regulatory elements of genes tested or in novel genes that are yet to be discovered.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22968740     DOI: 10.1007/s10875-012-9769-x

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  25 in total

1.  Successful bone marrow transplantation for DOCK8 deficient hyper IgE syndrome.

Authors:  Ayse Metin; Betul Tavil; Fatih Azık; Dilek Azkur; Ikbal Ok-Bozkaya; Can Kocabas; Bahattin Tunc; Duygu Uckan
Journal:  Pediatr Transplant       Date:  2012-01-17

2.  DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses.

Authors:  Yosuke Harada; Yoshihiko Tanaka; Masao Terasawa; Markus Pieczyk; Katsuyoshi Habiro; Tomoya Katakai; Kyoko Hanawa-Suetsugu; Mutsuko Kukimoto-Niino; Tomoko Nishizaki; Mikako Shirouzu; Xuefeng Duan; Takehito Uruno; Akihiko Nishikimi; Fumiyuki Sanematsu; Shigeyuki Yokoyama; Jens V Stein; Tatsuo Kinashi; Yoshinori Fukui
Journal:  Blood       Date:  2012-03-28       Impact factor: 22.113

3.  Curative treatment of autosomal-recessive hyper-IgE syndrome by hematopoietic cell transplantation.

Authors:  S A Gatz; U Benninghoff; C Schütz; A Schulz; M Hönig; U Pannicke; K-H Holzmann; K Schwarz; W Friedrich
Journal:  Bone Marrow Transplant       Date:  2010-07-12       Impact factor: 5.483

4.  Successful engraftment of donor marrow after allogeneic hematopoietic cell transplantation in autosomal-recessive hyper-IgE syndrome caused by dedicator of cytokinesis 8 deficiency.

Authors:  Douglas R McDonald; Michel J Massaad; Alicia Johnston; Sevgi Keles; Talal Chatila; Raif S Geha; Sung-Yun Pai
Journal:  J Allergy Clin Immunol       Date:  2010-12       Impact factor: 10.793

5.  Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.

Authors:  Yoshiyuki Minegishi; Masako Saito; Tomohiro Morio; Ken Watanabe; Kazunaga Agematsu; Shigeru Tsuchiya; Hidetoshi Takada; Toshiro Hara; Nobuaki Kawamura; Tadashi Ariga; Hideo Kaneko; Naomi Kondo; Ikuya Tsuge; Akihiro Yachie; Yukio Sakiyama; Tsutomu Iwata; Fumio Bessho; Tsutomu Ohishi; Kosuke Joh; Kohsuke Imai; Kazuhiro Kogawa; Miwa Shinohara; Mikiya Fujieda; Hiroshi Wakiguchi; Srdjan Pasic; Mario Abinun; Hans D Ochs; Eleonore D Renner; Annette Jansson; Bernd H Belohradsky; Ayse Metin; Norio Shimizu; Shuki Mizutani; Toshio Miyawaki; Shigeaki Nonoyama; Hajime Karasuyama
Journal:  Immunity       Date:  2006-11       Impact factor: 31.745

6.  Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.

Authors:  Shadi Al Khatib; Sevgi Keles; Maria Garcia-Lloret; Elif Karakoc-Aydiner; Ismail Reisli; Hasibe Artac; Yildiz Camcioglu; Haluk Cokugras; Ayper Somer; Necil Kutukculer; Mustafa Yilmaz; Aydan Ikinciogullari; Olcay Yegin; Mutlu Yüksek; Ferah Genel; Ercan Kucukosmanoglu; Ali Baki; Nerin N Bahceciler; Anupama Rambhatla; Derek W Nickerson; Sean McGhee; Isil B Barlan; Talal Chatila
Journal:  J Allergy Clin Immunol       Date:  2009-07-03       Impact factor: 10.793

7.  Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES).

Authors:  Wen-I Lee; Jing-Long Huang; Shy-Jae Lin; Kuo-Wei Yeh; Li-Chen Chen; Meng-Ying Hsieh; Yhu-Chering Huang; Ho-Chang Kuo; Kunder D Yang; Hong-Ren Yu; Tang-Her Jaing; Chih-Hsun Yang
Journal:  J Clin Immunol       Date:  2010-12-01       Impact factor: 8.542

Review 8.  Interplay of polarity proteins and GTPases in T-lymphocyte function.

Authors:  Ivan Fung; Sarah M Russell; Jane Oliaro
Journal:  Clin Dev Immunol       Date:  2012-02-22

Review 9.  Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome.

Authors:  Qian Zhang; Jeremiah C Davis; Christopher G Dove; Helen C Su
Journal:  Dis Markers       Date:  2010       Impact factor: 3.434

10.  Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production.

Authors:  Katrina L Randall; Teresa Lambe; Andy L Johnson; Andy Johnson; Bebhinn Treanor; Edyta Kucharska; Heather Domaschenz; Belinda Whittle; Lina E Tze; Anselm Enders; Tanya L Crockford; Tiphaine Bouriez-Jones; Duncan Alston; Jason G Cyster; Michael J Lenardo; Fabienne Mackay; Elissa K Deenick; Stuart G Tangye; Tyani D Chan; Tahra Camidge; Robert Brink; Carola G Vinuesa; Facundo D Batista; Richard J Cornall; Christopher C Goodnow
Journal:  Nat Immunol       Date:  2009-11-08       Impact factor: 25.606

View more
  25 in total

Review 1.  Insights into immunity from clinical and basic science studies of DOCK8 immunodeficiency syndrome.

Authors:  Helen C Su; Huie Jing; Pam Angelus; Alexandra F Freeman
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

2.  The clinical and laboratory spectrum of dedicator of cytokinesis 8 immunodeficiency syndrome in patients with a unique mutation.

Authors:  Arnon Broides; Amarilla B Mandola; Jacov Levy; Baruch Yerushalmi; Vered Pinsk; Michal Eldan; George Shubinsky; Nurit Hadad; Rachel Levy; Amit Nahum; Miriam Ben-Harosh; Atar Lev; Amos Simon; Raz Somech
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

Review 3.  DOCK8 deficiency: Insights into pathophysiology, clinical features and management.

Authors:  Catherine M Biggs; Sevgi Keles; Talal A Chatila
Journal:  Clin Immunol       Date:  2017-06-15       Impact factor: 3.969

4.  Vaccine strain varicella-zoster virus-induced central nervous system vasculopathy as the presenting feature of DOCK8 deficiency.

Authors:  Angela Sabry; Pia J Hauk; Huie Jing; Helen C Su; Nicholas V Stence; David M Mirsky; Maria A Nagel; Jordan K Abbott; Leonard L Dragone; Jennifer Armstrong-Wells; Donna J Curtis; Randall Cohrs; D Scott Schmid; Don Gilden; Erwin W Gelfand
Journal:  J Allergy Clin Immunol       Date:  2014-01-11       Impact factor: 10.793

5.  DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.

Authors:  Susanne E Aydin; Sara Sebnem Kilic; Caner Aytekin; Ashish Kumar; Oscar Porras; Leena Kainulainen; Larysa Kostyuchenko; Ferah Genel; Necil Kütükcüler; Neslihan Karaca; Luis Gonzalez-Granado; Jordan Abbott; Daifulah Al-Zahrani; Nima Rezaei; Zeina Baz; Jens Thiel; Stephan Ehl; László Marodi; Jordan S Orange; Julie Sawalle-Belohradsky; Sevgi Keles; Steven M Holland; Özden Sanal; Deniz C Ayvaz; Ilhan Tezcan; Hamoud Al-Mousa; Zobaida Alsum; Abbas Hawwari; Ayse Metin; Susanne Matthes-Martin; Manfred Hönig; Ansgar Schulz; Capucine Picard; Vincent Barlogis; Andrew Gennery; Marianne Ifversen; Joris van Montfrans; Taco Kuijpers; Robbert Bredius; Gregor Dückers; Waleed Al-Herz; Sung-Yun Pai; Raif Geha; Gundula Notheis; Carl-Philipp Schwarze; Betül Tavil; Fatih Azik; Kirsten Bienemann; Bodo Grimbacher; Valerie Heinz; H Bobby Gaspar; Roland Aydin; Beate Hagl; Benjamin Gathmann; Bernd H Belohradsky; Hans D Ochs; Talal Chatila; Ellen D Renner; Helen Su; Alexandra F Freeman; Karin Engelhardt; Michael H Albert
Journal:  J Clin Immunol       Date:  2015-01-28       Impact factor: 8.317

6.  Flow cytometry biomarkers distinguish DOCK8 deficiency from severe atopic dermatitis.

Authors:  Erin Janssen; Erdyni Tsitsikov; Waleed Al-Herz; Gerard Lefranc; Andre Megarbane; Majed Dasouki; Francisco A Bonilla; Talal Chatila; Lynda Schneider; Raif S Geha
Journal:  Clin Immunol       Date:  2013-12-31       Impact factor: 3.969

7.  Primary Immunodeficiency Diseases in Saudi Arabia: a Tertiary Care Hospital Experience over a Period of Three Years (2010-2013).

Authors:  Bandar Al-Saud; Hamoud Al-Mousa; Sulaiman Al Gazlan; Abdulaziz Al-Ghonaium; Rand Arnaout; Amal Al-Seraihy; Sahar Elshorbagi; Nazeema Elsayed; Jawad Afzal; Hasan Al-Dhekri; Saleh Al-Muhsen
Journal:  J Clin Immunol       Date:  2015-09-22       Impact factor: 8.317

Review 8.  Challenges and Clinical Implications of the Diagnosis of Cytomegalovirus Lung Infection in Children.

Authors:  Sonia M Restrepo-Gualteros; Maria J Gutierrez; Milena Villamil-Osorio; Maria A Arroyo; Gustavo Nino
Journal:  Curr Infect Dis Rep       Date:  2019-05-30       Impact factor: 3.725

9.  Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotype.

Authors:  Huie Jing; Qian Zhang; Yu Zhang; Brenna J Hill; Christopher G Dove; Erwin W Gelfand; T Prescott Atkinson; Gulbu Uzel; Helen F Matthews; Peter J Mustillo; David B Lewis; Fotini D Kavadas; I Celine Hanson; Ashish R Kumar; Raif S Geha; Daniel C Douek; Steven M Holland; Alexandra F Freeman; Helen C Su
Journal:  J Allergy Clin Immunol       Date:  2014-05-03       Impact factor: 10.793

Review 10.  Recent Advances in DOCK8 Immunodeficiency Syndrome.

Authors:  Qian Zhang; Huie Jing; Helen C Su
Journal:  J Clin Immunol       Date:  2016-05-20       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.